Max van Min is co-founder and CEO of Cergentis. He obtained a degree in biotechnology at the Wageningen University & Research Centre and has since worked in commercial management positions in the life sciences industry. Van Min is, together with Prof. Wouter de Laat of the Hubrecht Institute, inventor of the TLA Technology (Nature Biotechnology 2014). The TLA Technology enables targeted complete next-generation sequencing and haplotyping of genes of interest and has important applications in the development and implementation of personalized medicine.
Associated Grants
-
GBA Sequencing and Detection of Mutations, Deletions, Insertions and Recombinations with the GBA Pseudo Gene
2019
-
Developing New Method for GBA sequencing and Detection of Germ-line or Somatic Point Mutations, Deletion/Insertions and Recombinations with the GBA Pseudo Gene
2016